What is 98point6?
Founded in 2015 and headquartered in Seattle, 98point6 operates as an on-demand, text-based virtual primary care clinic. By leveraging proprietary artificial intelligence and machine learning, the company provides a seamless, accessible interface for patients to connect with board-certified physicians. This model addresses the critical need for efficient, high-quality healthcare delivery, positioning 98point6 as a key player in the digital transformation of the primary care landscape. The company's focus on enterprise-level integration allows it to serve self-insured employers and large-scale organizations, effectively bridging the gap between traditional clinical care and modern, technology-driven health solutions.
How much funding has 98point6 raised?
98point6 has raised a total of $293M across 8 funding rounds:
Series A
$750K
Debt
$11M
Series B
$19.5M
Series C
$50M
Series D
$43M
Series E
$118M
Other Financing Round
$20M
Other Financing Round
$30.7M
Series A (2015): $750K, investors not publicly disclosed
Debt (2016): $11M, investors not publicly disclosed
Series B (2017): $19.5M, investors not publicly disclosed
Series C (2018): $50M featuring Goldman Sachs
Series D (2020): $43M backed by Goldman , Sachs & Co.
Series E (2020): $118M with participation from Activant Capital Group LLC, L Catterton Management Limited, and The Goldman Sachs Group, Inc.
Other Financing Round (2022): $20M led by L Catterton and Activant Capital Group
Other Financing Round (2023): $30.7M supported by Transcarent, Activant Capital Group, and L Catterton
Key Investors in 98point6
Transcarent
Transcarent is a comprehensive health and care platform designed for self-insured employers, connecting employees and their families to medical advisors and actionable health information.
Activant Capital Group
Activant is a research-led growth firm that invests in founders building innovative solutions to automate enterprise workflows and digitize global operations.
L Catterton
L Catterton is a global consumer-focused private equity firm that deploys capital through flagship buyout and growth strategies across diverse international markets.
What's next for 98point6?
With the infusion of $30.7M, 98point6 is well-positioned to accelerate its growth strategy and deepen its penetration into the enterprise health market. The company is expected to focus on enhancing its clinical AI capabilities and expanding its service offerings to meet the increasing demand for integrated, virtual-first care models. By aligning with strategic partners such as Transcarent, 98point6 is poised to leverage synergies that will likely drive long-term value for stakeholders and improve patient outcomes. Future initiatives will likely center on operational scaling, technological refinement, and the continued pursuit of market leadership in the competitive digital health ecosystem.
See full 98point6 company page
